Efficacy and dosimetry of computed tomography image-guided 125I radioactive seed implantation for locally recurrent rectal cancer
Wang Hao,Wang Junjie,Yuan Huishu,Jiang Yuliang,Tian Suqing,Liu Chen,Li Jinna,Yang Ruijie,Sun Haitao
Department ofRadiation Oncology (Wang H,Wang JJ,Jiang YL,Tian SQ,Li JN,Yang RJ,Sun HT), Department of Radiology (Yuan HSH,Liu Ch),Peking University Third Hospital,Beijing 100191,China
Abstract： Objective To evaluate the efficacy of computed tomography (CT) image-guided 125I radioactive seed implantation for locally recurrent rectal cancer (LRRC), and to analyze the relationship between the dosimetry and prognosis. Methods A retrospective analysis was performed on the clinical data of 36 patients with LRRC who received CT image-guided 125I seed implantation in our hospital from 2003 to 2011. Dosimetric verification was performed using CT scan immediately after 125I seed implantation. The D90, D100, V100, and V150 values were evaluated. In all the patients, the median activity of seeds was 0.7 mCi (0.4-0.8 mCi) and the median number of implanted seeds was 74(33-137). The local control (LC) and overall survival (OS) rates were calculated using the Kaplan-Meier method. The log-rank test and Cox regression model were used for the univariate and multivariate analyses, respectively. Results The median OS time was 16.2 months (95% CI=13.5-18.9 months). The median LC time was 10.0 months (95% CI=6.2-13.8 months). The D90 and V100 values were (118.6±25.1) Gy and (90.0±0.3)%, respectively. The univariate analysis suggested that D90 was correlated with the LC time (P=0.048) and V100 was correlated with the OS time (P=0.035). The multivariate analysis showed that a V100 value higher than 90% was a prognostic factor of OS (P=0.044). Conclusions In the treatment of LRRC using CT image-guided 125I radioactive seed implantation, a D90 value larger than 140 Gy and a V100 value higher than 90% in the postoperative verification plan help improve the LC and OS rates. The D90 and V100 values in the postoperative verification plan may predict treatment outcomes in patients.
Wang Hao,Wang Junjie,Yuan Huishu et al. Efficacy and dosimetry of computed tomography image-guided 125I radioactive seed implantation for locally recurrent rectal cancer[J]. Chinese Journal of Radiation Oncology, 2016, 25(10): 1096-1099.
[1] Chen WQ,Zheng RS,Baade PD,et al. Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338. [2] Siegel RL,Miller KD and Jemal A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30.DOI:10.3322/caac.21332. [3] Camilleri-Brennan J,Steele RJC.The impact of recurrent rectal cancer on quality of life[J].Eur J Surg Oncol,2001,27(4):349-353.DOI:10.1053/ejso.2001.1115. [4] National Comprehensive Cancer Networks (NCCN).The NCCN rectal cancer clinical practice guidelines in oncology (version 1.2016)[EB/OL].[2016-02-05] http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. [5] Nielsen MB,Laurberg S,Holm T.Current management of locally recurrent rectal cancer[J].Colorectal Dis,2011,13(7):732-742.DOI:10.1111/j.1463-1318.2009.02167.x. [6] Guren MG,Undseth C,Rekstad BL,et al. Reirradiation of locally recurrent rectal cancer:a systematic review[J].Radiother Oncol,2014,113(2):151-157.DOI:10.1016/j.radonc.2014.11.021. [7] Alberda WJ,Haberkorn BC,Morshuis WG,et al. Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area[J].Int J Colorectal Dis,2015,30(8):1075-1080.DOI:10.1007/s00384-015-2270-2. [8] Klose J,Tarantino I,Schmidt T,et al. Impact of anatomic location on locally recurrent rectal cancer:superior outcome for intraluminal tumour recurrence[J].J Gastroint Surg,2015,19(6):1123-1131.DOI:10.1007/ s11605-015-2804-5. [9] Selvaggi F,Fucini C,Pellino G,et al. Outcome and prognostic factors of local recurrent rectal cancer:a pooled analysis of 150 patients[J].Tech Coloproctol,2015,19(3):135-144.DOI:10.1007/s10151-014-1241-x. [10] Palmer G,Martling A,Cedermark B,et al. A population-based study on the management and outcome in patients with locally recurrent rectal cancer[J].Ann Surg Oncol,2007,14(2):447-454.DOI:10.1245/s10434-006-9256-9. [11] Harris CA,Solomon MJ,Heriot AG,et al. The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer[J].Ann Surg,2015.DOI:10.1097/SLA.0000000000001524. [12] Haddock MG,Gunderson LL,Nelson H,et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients[J].Int J Radiat Oncol Biol Phys,2001,49(5):1267-1274.DOI:10.1016/S0360-3016(00) 01528-5. [13] Wiig JN,Giercksky KE,Tveit KM.Intraoperative radiotherapy for locally advanced or locally recurrent rectal cancer:does it work at all?[J].Acta Oncol,2014,53(7):865-876.DOI:10.3109/0284186X.2014.895037. [14] Wang JJ,Yuan HS,Li JN,et al. Interstitial permanent implantation of 125I seeds as salvage therapy for re-recurrent rectal carcinoma[J].Int J Colorectal Dis,2009,24(4):391-399.DOI:10.1007/s00384-008-0628-4. [15] Wang JJ,Yuan HS,Li JN,et al. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy[J].Med Oncol,2010,27(2):421-429.DOI:10.1007/ s12032-009-9227-7. [16] Wang ZM,Lu J,Liu L,et al. Clinical application of CT-guided 125I seed interstitial implantation for local recurrent rectal carcinoma[J].Radiat Oncol,2011,6(1):138.DOI:10.1186/1748-717X-6-138. [17] 杨瑞杰,姜玉良,李金娜,等.复发性直肠癌CT引导125I粒子植入的剂量学验证[J].中国肿瘤,2009,18(10):848-850. Yang RJ,Jiang YL,Li JN,et al. Dosimetric verification of CT-guided 125I seed implantation in recurrent rectal cancer[J].Chin Cancer,2009,18(10):848-850.
2016, Vol. 25 
